Gladstone Institutional Advisory LLC Has $304,000 Holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Gladstone Institutional Advisory LLC lifted its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHCFree Report) by 27.6% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 3,938 shares of the company’s stock after buying an additional 851 shares during the quarter. Gladstone Institutional Advisory LLC’s holdings in GE HealthCare Technologies were worth $304,000 at the end of the most recent quarter.

Several other institutional investors also recently modified their holdings of GEHC. Allspring Global Investments Holdings LLC grew its position in shares of GE HealthCare Technologies by 2.6% during the 3rd quarter. Allspring Global Investments Holdings LLC now owns 26,418 shares of the company’s stock worth $1,797,000 after buying an additional 675 shares during the period. Private Advisor Group LLC grew its position in shares of GE HealthCare Technologies by 20.0% during the 3rd quarter. Private Advisor Group LLC now owns 23,596 shares of the company’s stock worth $1,605,000 after buying an additional 3,925 shares during the period. MGO One Seven LLC acquired a new stake in shares of GE HealthCare Technologies during the 3rd quarter worth approximately $333,000. ORG Partners LLC grew its position in shares of GE HealthCare Technologies by 174.2% during the 3rd quarter. ORG Partners LLC now owns 425 shares of the company’s stock worth $29,000 after buying an additional 270 shares during the period. Finally, Nomura Asset Management Co. Ltd. grew its position in shares of GE HealthCare Technologies by 1.7% during the 3rd quarter. Nomura Asset Management Co. Ltd. now owns 113,266 shares of the company’s stock worth $7,707,000 after buying an additional 1,919 shares during the period. Institutional investors and hedge funds own 82.06% of the company’s stock.

GE HealthCare Technologies Stock Performance

Shares of GEHC opened at $79.33 on Friday. The company has a debt-to-equity ratio of 1.11, a quick ratio of 0.83 and a current ratio of 1.06. GE HealthCare Technologies Inc. has a twelve month low of $62.35 and a twelve month high of $94.50. The firm’s 50 day moving average price is $85.31 and its two-hundred day moving average price is $80.41. The firm has a market cap of $36.21 billion, a P/E ratio of 23.20, a PEG ratio of 2.90 and a beta of 1.26.

GE HealthCare Technologies (NASDAQ:GEHCGet Free Report) last announced its quarterly earnings data on Tuesday, April 30th. The company reported $0.90 EPS for the quarter, hitting analysts’ consensus estimates of $0.90. The business had revenue of $4.65 billion for the quarter, compared to analyst estimates of $4.80 billion. GE HealthCare Technologies had a net margin of 8.05% and a return on equity of 25.32%. The firm’s revenue for the quarter was down 1.2% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.85 earnings per share. On average, analysts forecast that GE HealthCare Technologies Inc. will post 4.27 EPS for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, May 15th. Stockholders of record on Friday, April 19th were given a $0.03 dividend. This represents a $0.12 dividend on an annualized basis and a dividend yield of 0.15%. The ex-dividend date was Thursday, April 18th. GE HealthCare Technologies’s dividend payout ratio is presently 3.51%.

Insider Transactions at GE HealthCare Technologies

In other GE HealthCare Technologies news, insider Frank R. Jimenez acquired 1,315 shares of the business’s stock in a transaction dated Wednesday, May 1st. The shares were acquired at an average price of $76.52 per share, with a total value of $100,623.80. Following the completion of the transaction, the insider now directly owns 75,796 shares in the company, valued at approximately $5,799,909.92. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. In other news, insider Frank R. Jimenez purchased 1,315 shares of the company’s stock in a transaction on Wednesday, May 1st. The shares were purchased at an average cost of $76.52 per share, with a total value of $100,623.80. Following the completion of the transaction, the insider now owns 75,796 shares of the company’s stock, valued at approximately $5,799,909.92. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, CEO Jan Makela sold 66,955 shares of the company’s stock in a transaction on Wednesday, May 15th. The stock was sold at an average price of $81.54, for a total transaction of $5,459,510.70. Following the sale, the chief executive officer now directly owns 63,348 shares in the company, valued at $5,165,395.92. The disclosure for this sale can be found here. 0.27% of the stock is currently owned by insiders.

Analysts Set New Price Targets

Several equities research analysts have recently commented on GEHC shares. Mizuho lowered their price target on shares of GE HealthCare Technologies from $110.00 to $105.00 and set a “buy” rating for the company in a research report on Wednesday, May 1st. Morgan Stanley boosted their price objective on shares of GE HealthCare Technologies from $74.00 to $86.00 and gave the company an “equal weight” rating in a report on Monday, February 12th. Citigroup boosted their price objective on shares of GE HealthCare Technologies from $88.00 to $103.00 and gave the company a “buy” rating in a report on Wednesday, April 3rd. Argus boosted their price objective on shares of GE HealthCare Technologies from $80.00 to $110.00 and gave the company a “buy” rating in a report on Monday, April 1st. Finally, Evercore ISI boosted their price objective on shares of GE HealthCare Technologies from $93.00 to $100.00 and gave the company an “outperform” rating in a report on Thursday, April 4th. Four research analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. According to data from MarketBeat, GE HealthCare Technologies has a consensus rating of “Moderate Buy” and a consensus price target of $94.80.

Get Our Latest Stock Report on GE HealthCare Technologies

GE HealthCare Technologies Company Profile

(Free Report)

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.

Featured Articles

Institutional Ownership by Quarter for GE HealthCare Technologies (NASDAQ:GEHC)

Receive News & Ratings for GE HealthCare Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GE HealthCare Technologies and related companies with MarketBeat.com's FREE daily email newsletter.